Becton Dickinson & Co (BDX)

Explore Becton Dickinson & Co (BDX) share price insights and trends for smarter investment strategies. Stay informed with FP Markets Senegal.

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Becton Dickinson & Co (BDX) Profile

Becton Dickinson & Co (BDX.xnys) is a multinational medical technology company headquartered in Franklin Lakes, New Jersey, United States. Becton Dickinson manufactures and sells medical services, instrument systems and reagents. Additionally provides consulting and analytics services in certain geographies. The company is divided into 3 segments, BD Medical, BD Interventional and BD Life Sciences. Becton Dickinson services include diabetes care, medication delivery solutions, medication management solutions, pharmaceutical systems, peripheral intervention, surgery, urology and critical care, biosciences, and integrated diagnostic solutions. Becton Dickinson has 92 office locations across 47 countries and employs more than 76,000 people. Becton Dickinson stock (BDX) is listed on the New York Stock Exchange (NYSE), had a market capitalisation of $75.21B (USD) as of January 2022 and $17.12B (USD) in 2020 yearly revenues. In late 2021, Becton Dickinson announced a collaboration with Pfizer Inc and Wellcome (a global charitable foundation) to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world. This collaboration will survey existing diagnostic practices to highlight both benefits and gaps in diagnostic testing in AMR stewardship to improve further avocado for patient care, clinical practice and health care economics.

Start Trading Becton Dickinson & Co (BDX) with a Market Leader Today

Becton Dickinson & Co (BDX) Trading FAQ

Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.

Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.

Start Trading
in minutes

Get instant Updates in Telegram